PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

19 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Cobo, M.F.L.* et al.: Single cell identification of defined ebv epitope-specific TCR alpha beta pairs for adoptive T cell transfer against EBV infection and EBV-associated malignancies. Bone Marrow Transplant. 54, 177-178 (2019)
2.
Freudenreich, M.* et al.: Clinical relevance of in vitro generation of dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS. Bone Marrow Transplant. 54, 145-145 (2019)
3.
Ritter, I.* et al.: T-cell receptor deep sequencing analysis of EBV specific T cells before and after adoptive transfer in a patient after allogeneic stem cell transplantation. Bone Marrow Transplant. 50, S400 (2015)
4.
Klar, R.* et al.: Immunoproteomic identification of naturally presented epitopes presented on primary myeloid leukaemia cells and their potential as targets for T-cell receptor gene modified donor lymphocyte infusions. Bone Marrow Transplant. 48, S74-S75 (2013)
5.
Burdach, S.* et al.: Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases. Bone Marrow Transplant. 45, 483-489 (2010)
6.
Buhmann, R. et al.: Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion. Bone Marrow Transplant. 43, 383-397 (2009)
7.
Zorn, J. ; Herber, M. ; Schwamberger, S. ; Adler, H. & Kolb, H.-.: Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion. Bone Marrow Transplant. 41, S127-S128 (2008)
8.
Munker, R.* ; Schmid, C.* ; Madrigal, J.A.* & Kolb, H.-J.: An update on graft-versus-host and graft-versus-leukemia reactions: A summary of the sixth International Symposium held in Schloss Elmau. Bone Marrow Transplant. 34, 767-780 (2004)
9.
Munker, R.* ; Günther, W. & Kolb, H.-J.: New concepts about graft-versus-host and graft-versus-leukaemia-reactions : a summary of the 5. International Symposium in Munich. Bone Marrow Transplant. 30, 549-556 (2002)
10.
Pihusch, R.* et al.: The impact of antithymocyte globulin on short-term toxicity after allogenic stem cell transplantation. Bone Marrow Transplant. 30, 347-354 (2002)
11.
Pihusch, R.* et al.: Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 30, 381-387 (2002)
12.
Holler, E. et al.: Prognostic significance of increased IL-10 production in patients prior to allogenic bone marrow transplantation. Bone Marrow Transplant. 25, 237-241 (2000)
13.
Pohla, H.* et al.: Allogeneic vaccianation for renal cell carcinoma: development and monitoring. Bone Marrow Transplant. 25, 2, 83-87 (2000)
14.
Bornkamm, G.W. & Jacobsen, N.R.: Viral infections and antiviral immunity. Bone Marrow Transplant. 12, S88-S89 (1993)
15.
Dörmer, P. & Gianni, A.M.: Stem cell physiology - role of CD34. Bone Marrow Transplant. 12 (Suppl.4), 120-122 (1993)
16.
Dörmér, P.G. & Gianni, A.M.: Stem cell physiology - Role of CD34. Bone Marrow Transplant. 12, S120-S122 (1993)
17.
Holler., E. ; Kolb, H.J. & Wilmanns, W.: Treatment of GVHD-TNF-antibodies and related antagonists. Bone Marrow Transplant. 12, S29-S31 (1993)
18.
Thierfelder, S.S.: Antibody-induced suppression of graft versus host disease, animal models. Bone Marrow Transplant. 12, S6-S8 (1993)
19.
Kolb, H.J. et al.: Cancer after bone marrow transplantation. Bone Marrow Transplant. 10, 135-138 (1992)
▮◀ ◀◀ ▶▶ ▶▮